| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/OXFORDJOURNALS.BMB.A072408 |
| P698 | PubMed publication ID | 2116212 |
| P50 | author | Michael Houghton | Q1927895 |
| P2093 | author name string | Bradley DW | |
| Weiner AJ | |||
| Choo QL | |||
| Kuo G | |||
| Overby LR | |||
| P433 | issue | 2 | |
| P921 | main subject | virus | Q808 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 423-441 | |
| P577 | publication date | 1990-04-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | British Medical Bulletin | Q15750363 |
| P1476 | title | Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis | |
| P478 | volume | 46 |
| Q42597935 | 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region |
| Q30847495 | A genomic approach of the hepatitis C virus generates a protein interaction map. |
| Q27485690 | Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology |
| Q70590241 | An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C |
| Q30485092 | An overview of triple infection with hepatitis B, C and D viruses |
| Q42985252 | Analysis of genomic variability of hepatitis C virus |
| Q45758901 | Antibodies to Hepatitis C Virus in Chandigarh Blood Donors |
| Q37262369 | Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major |
| Q42994244 | Assay for hepatitis C virus in peripheral blood mononuclear cells enhances sensitivity of diagnosis and monitoring of HCV-associated hepatitis |
| Q42982426 | Association of hepatitis C virus in human sera with beta-lipoprotein |
| Q43039062 | Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients |
| Q37137656 | At least five related, but distinct, hepatitis C viral genotypes exist |
| Q42990741 | Automation of Polymerase Chain Reaction-Based Systems for Detection of Hepatitis C Virus RNA |
| Q59349123 | Autophagy: The multi-purpose bridge in viral infections and host cells |
| Q27469669 | Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection |
| Q28377294 | Biochemical properties of a minimal functional domain with ATP-binding activity of the NTPase/helicase of hepatitis C virus |
| Q42981306 | Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells |
| Q29620816 | Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end |
| Q77598656 | Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients |
| Q30431528 | Chronic hepatitis C: the virus, its discovery and the natural history of the disease |
| Q43048266 | Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes |
| Q27477946 | Clinical guidelines on the management of hepatitis C |
| Q43035669 | Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Role of serology and HCV RNA detection. |
| Q41841986 | Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy |
| Q92087119 | Comparative Analysis of Electrochemiluminescence Assay and Chemiluminescent Microparticle Immunoassay for the Screening of Hepatitis C |
| Q34556313 | Comparative pathogenesis of HBV and HCV. |
| Q42993471 | Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients |
| Q42985310 | Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay |
| Q36390620 | Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro |
| Q43049359 | Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins |
| Q43037729 | Detection of HCV RNA in serum and seminal fluid from HIV‐1 co‐infected intravenous drug addicts |
| Q37012541 | Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope |
| Q43039123 | Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides |
| Q43048952 | Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients |
| Q27485151 | Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients |
| Q43039519 | Detection of hepatitis C virus RNA in serum, by combining reverse transcription and polymerase chain reaction in one tube |
| Q42983051 | Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients |
| Q43048410 | Development of a specific enzyme-linked immunosorbent assay for the hepatitis C virus antibody using clone 14. |
| Q37262716 | Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease |
| Q27485762 | Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors |
| Q35022787 | Dynamic coinfection with multiple viral subtypes in acute hepatitis C. |
| Q33755441 | Early events in hepatitis C virus infection of chimpanzees. |
| Q34294938 | Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection |
| Q33972219 | Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples |
| Q38074272 | Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance |
| Q42997317 | Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies |
| Q29615900 | Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections |
| Q27486022 | Expression and identification of hepatitis C virus polyprotein cleavage products |
| Q42993049 | Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system |
| Q35861153 | FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53. |
| Q45739675 | Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopes |
| Q72574433 | Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test |
| Q27860507 | Genetic organization and diversity of the hepatitis C virus |
| Q42979026 | Genotype determination of hepatitis C virus from northern India: identification of a new subtype |
| Q43041871 | Genotypic analysis of hepatitis C virus in American patients |
| Q27485608 | Genotyping of hepatitis C virus isolates from Basque Country, Spain |
| Q27485672 | Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China |
| Q43038401 | HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. |
| Q43036975 | Hepatitis A, B and C seroprevalence in Pakistan |
| Q43038907 | Hepatitis C Virus (HCV) RNA among Anti-HCV-Positive Blood Donors and Their Recipients |
| Q43038916 | Hepatitis C Virus Blood Donor Screening Recombinant Immunoblot Assay Interpretation Re-Examined |
| Q42984218 | Hepatitis C Virus in Fulminant Hepatic Failure |
| Q37593216 | Hepatitis C Virus-Induced Rab32 Aggregation and Its Implications for Virion Assembly |
| Q37299112 | Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda |
| Q42980645 | Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis |
| Q68264325 | Hepatitis C virus |
| Q27486377 | Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro |
| Q42983355 | Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection |
| Q42982870 | Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association |
| Q45854220 | Hepatitis C virus antibodies among risk groups in Turkey |
| Q43038890 | Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus |
| Q59830083 | Hepatitis C virus antibodies in acute and chronic liver disease in India |
| Q42992110 | Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia |
| Q43041842 | Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes |
| Q45229171 | Hepatitis C virus infection in infants whose mothers took illicit drugs intravenously |
| Q42984920 | Hepatitis C virus infection in infants whose mothers took street drugs intravenously |
| Q43032866 | Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia |
| Q34370414 | Hepatitis C virus infection in pediatric patients |
| Q41225114 | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa |
| Q45745945 | Hepatitis C virus prevalence among an immigrant community to the southern Amazon, Brazil |
| Q34769865 | Hepatitis C virus, B-cell proliferation and lymphomas. |
| Q27469295 | Hepatitis C virus. A review |
| Q34429535 | Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system |
| Q27473549 | Hepatitis C: a possible etiology for cryoglobulinaemia type II |
| Q35233238 | Hepatitis C: virology, epidemiology, clinical course, and treatment |
| Q56985245 | Hepatitis E virus |
| Q27486176 | Hepatology |
| Q45859729 | High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate? |
| Q26767036 | Historical review of the causes of cancer |
| Q40612869 | Human immunodeficiency virus and hepatitis--implications for operating room personnel |
| Q27473523 | Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1 |
| Q28139634 | Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus |
| Q27488201 | Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region |
| Q42981920 | Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients |
| Q73260241 | Immunopathogenesis of hepatitis C virus infection |
| Q42980917 | Improved detection of hepatitis c virus antibodies in high-risk populations |
| Q27469851 | Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity |
| Q43036558 | Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides |
| Q36929351 | Liver Enzymes in Children with beta-Thalassemia Major: Correlation with Iron Overload and Viral Hepatitis. |
| Q72421238 | Liver disease |
| Q67993656 | Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis |
| Q91950568 | Low Prevalence of Hepatitis C Virus Genotype -1b in Chronic Liver Disease Patients in India |
| Q43035572 | Low prevalence of anti-HCV antibodies in hospital workers |
| Q27477626 | Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting |
| Q27488210 | Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 |
| Q41332801 | Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups |
| Q28083478 | Molecular biology of hepatitis B virus infection |
| Q36441749 | Molecular biology of non-A, non-B hepatitis agents: hepatitis C and hepatitis E viruses |
| Q29619801 | Nucleotide sequence and mutation rate of the H strain of hepatitis C virus |
| Q34807255 | Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy |
| Q27480288 | Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients |
| Q27472872 | Oligomerization and Cooperative RNA Synthesis Activity of Hepatitis C Virus RNA-Dependent RNA Polymerase |
| Q33720363 | Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. |
| Q41051463 | Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis |
| Q40649145 | Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection |
| Q37189032 | Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection |
| Q34499902 | Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant |
| Q43035611 | Perspectives: towards a peptide-based vaccine against hepatitis C virus. |
| Q71660465 | Preliminary results of beta-interferon treatment in the elderly |
| Q27477924 | Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients |
| Q45769804 | Prevalence of antibodies to hepatitis C virus among normal blood donors and multi-transfused sickle-cell anaemia patients in Nigeria |
| Q27472984 | Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France |
| Q42995517 | Protein kinase C recognizes the protein kinase A-binding motif of nonstructural protein 3 of hepatitis C virus |
| Q46079286 | Pruritus as a symptom of hepatitis C. |
| Q42997496 | Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha |
| Q27487881 | Quantitation of hepatitis C virus genome molecules in plasma samples |
| Q37359927 | Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection |
| Q40888842 | Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles |
| Q39254956 | Rab32 subfamily small GTPases: pleiotropic Rabs in endosomal trafficking |
| Q42981289 | Rapid and sensitive genotyping of hepatitis C virus by single-strand conformation polymorphism. |
| Q27485768 | Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system |
| Q72278427 | Rheumatic manifestations of hepatitis C infection |
| Q33883607 | Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B |
| Q44727301 | Routine laboratory diagnosis of hepatitis C virus infection |
| Q42980642 | Sensitivity of an anti‐HCV core peptide ELISA |
| Q37519291 | Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus |
| Q42981288 | Serodiagnostic Assay of Hepatitis C Virus Infection Using Viral Proteins Expressed in Escherichia coli |
| Q42982979 | Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease |
| Q52265480 | Serum antibodies to hepatitis C virus: analysis of risk factors of seropositivity in a population of blood donors in metropolitan France |
| Q33589343 | Sexual transmission of hepatitis C virus infection |
| Q33933564 | Sexually transmitted hepatitis: a review |
| Q27488873 | Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus |
| Q33730330 | Structure-Based Library Design in Efficient Discovery of Novel Inhibitors |
| Q43745299 | Study of HCV infection and viremia in patients with posttransfusion hepatitis in China |
| Q27478443 | Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase |
| Q58802894 | T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections |
| Q27477700 | Testing for hepatitis C virus |
| Q42995296 | The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold |
| Q37815171 | The hepatitis viruses. A review. |
| Q27329756 | The p7 Protein of Hepatitis C Virus Forms Structurally Plastic, Minimalist Ion Channels |
| Q45721974 | The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India |
| Q77326340 | Transfusion virology: progress and challenges |
| Q27488858 | Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma |
| Q39192032 | Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients |
| Q29620952 | Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins |
| Q41134456 | Vertical transmission of hepatitis C virus |
| Q68008537 | Viral hepatitis |
| Q35228510 | Virology, Molecular Biology, and Serology of Hepatitis C Virus |
| Q32159849 | Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection |
| Q45003215 | [Hepatitis C virus] |
Search more.